A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis
Cdkn2ab knockout mice develop skin tumours but this phenotype is lost on backcrossing of the mice. Here, the authors describe a genetic variant encompassing Wnt7b that synergises with Cdkn2ab loss and is required for tumour formation in these mice.
Guardado en:
Autores principales: | Paul Krimpenfort, Margriet Snoek, Jan-Paul Lambooij, Ji-Ying Song, Robin van der Weide, Rajith Bhaskaran, Hans Teunissen, David J. Adams, Elzo de Wit, Anton Berns |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/88bea2f7c3a344d1b33663cb6275c20c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
por: Patrice Dubreuil, et al.
Publicado: (2009) -
Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Ashutosh Kumar Arya, et al.
Publicado: (2017) - Carcinogenesis
-
Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui X, et al.
Publicado: (2021) -
Journal of carcinogenesis
Publicado: (2002)